Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDHP5303/12
CompoundBurprenorphine
Trials sponsorGrünenthal GmbH
Trial phase1
Brief titleMultiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations
IndicationHealthy
UTN
CTG IDNCT00469053
CTIS ID (former EudraCT)2007-000667-22
Trial statusTerminated
FPIMay 21, 2007
LPOSeptember 4, 2007
CountriesGermany
GenderMale
Age18 Years to 55 Years
ResultsNo
Pubmed
Documents